-
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
ソース: Buzz FX / 25 2 2025 01:51:17 America/Chicago
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat February 25, 2025 Share Link copied to clipboard. BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Free Report ) has receive
Read more...